Kishore Kumar, MD
Gastroenterology · Scranton, PANPI 1649526369
Payments from drug & device makers
Across 45 payments — averaging $122.80 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Olympus Corporation Of The Americas$3K
- Boston Scientific$2K
- Cook Incorporated$500
- Endogastric Solutions, Inc$197
- Janssen Scientific Affairs, LLC$161
- Intercept Pharmaceuticals, Inc.$128
- plus $405 from 6 others
What the payments were for
- Speaking & faculty fees$5009%
- Travel & lodging$3,68967%
- Food & beverage$1,27223%
- Education$651%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Olympus Corporation Of The Americas | 20 | $2,507 |
| Boston Scientific | 12 | $1,628 |
| Cook Incorporated | 1 | $500 |
| Endogastric Solutions, Inc | 2 | $197 |
| Janssen Scientific Affairs, LLC | 2 | $161 |
| Intercept Pharmaceuticals, Inc. | 1 | $128 |
| Ardelyx, Inc. | 1 | $125 |
| Merit Medical Systems Inc | 1 | $76 |
| Fujifilm Healthcare Americas Corporation | 1 | $75 |
| Covidien LP | 1 | $65 |
| Micro-tech Endoscopy USA, Inc. | 2 | $38 |
| Conmed Corporation | 1 | $27 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Single Use Electrosurgical Knife KD-655$2,169
- ORISE$1,312
- DISPOSABLE DISTAL ATTACHMENT$1,113
- Single Use Electrosurgical Hemostatic Forceps$1,056
- ESOPHYX$129
- OCALIVA$128
- IBSRELA$125
How this compares
$5,526 in reported general payments places this provider in the 65th percentile of 935 gastroenterology providers in Pennsylvania.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Omeprazole | 79 | $1,256 |
| Pantoprazole Sodium | 35 | $410 |
| Famotidine | 24 | $243 |
| Diltiazem Hcl | 11 | $181 |
Paid to pharmacies, not to this prescriber.
Other gastroenterology in Scranton
- Kuchikala ReddyPhiladelphia$6.5M
- Glenn FreedPottsville$3.8M
- Nirav ShahWyomissing$3.5M
- Jaideep BehariPittsburgh$2.7M
- Adnan AhmadCamp Hill$2.1M
- Frederick RuthardtUniontown$1.7M
- Adam PeytonAllentown$1.6M
- Dina Halegoua de MarzioPhiladelphia$1.5M
- Miguel RegueiroPittsburgh$1.5M
- Gary FalkPhiladelphia$1.4M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.